Innovative therapeutics

Investors

IR Snapshot

NASDAQBMRN
Beta1.64
Shares Outstanding178.1M
Average Volume (10 days)978.2K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($0.71)
Sales (TTM)$6.31
Book Value (MRQ)$16.37
Cash Flow (TTM)($0.08)
Cash (MRQ)$8.13

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy14
 
Buy1
 
Hold4
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Jean-Jacques Bienaime
Director, Chief Executive Officer
(4,000)
Sell
Jan 14, 2019
Jean-Jacques Bienaime
Director, Chief Executive Officer
(3,000)
Sell
Jan 10, 2019
Jean-Jacques Bienaime
Director, Chief Executive Officer
(3,401)
Sell
Jan 8, 2019
Jean-Jacques Bienaime
Director, Chief Executive Officer
(1,599)
Sell
Jan 8, 2019
Jean-Jacques Bienaime
Director, Chief Executive Officer
(1,000)
Sell
Jan 8, 2019

Recent SEC Filings

Insider Buy/Sell
Jan 15, 2019
Insider Buy/Sell
Jan 11, 2019
Insider Buy/Sell
Jan 10, 2019
Insider Buy/Sell
Jan 9, 2019
Company Events
Jan 8, 2019

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information